Negatively regulating TLR4/NF-κB signaling via PPARα in endotoxin-induced uveitis

Area of Science:

• Immunology
• Ophthalmology
• Molecular Biology

Background:

• Toll-like receptor (TLR) signaling is crucial in autoimmune disease development.
• Lipopolysaccharide (LPS), a TLR4 ligand, acts as an antagonist to peroxisome proliferator-activated receptor alpha (PPARα).

Purpose of the Study:

• To investigate the regulatory role of PPARα in TLR signaling during endotoxin-induced uveitis (EIU).
• To evaluate fenofibrate, a PPARα agonist, as a potential therapeutic agent for uveitis.

Main Methods:

• Utilized the endotoxin-induced uveitis (EIU) mouse model.
• Administered fenofibrate (PPARα agonist) to assess its effects on inflammation and TLR/NF-κB signaling.
• Conducted in vitro studies using RPE cells and TLR4-expressing reporter cells.

Main Results:

• PPARα activation by fenofibrate significantly ameliorated LPS-induced uveitis.
• Fenofibrate treatment reduced inflammatory cell infiltration, protein concentration, cytokine production, and improved retinal function.
• PPARα negatively regulates TLR4 expression and inhibits NF-κB activation, thereby exerting anti-inflammatory effects.

Conclusions:

• PPARα activation is a novel therapeutic strategy for human uveitis.
• PPARα exerts anti-inflammatory actions by negatively regulating TLR4 activity and downstream NF-κB signaling.